Pain response and quality of life assessment in patients with moderate/severe neuropathic pain due to bone metastasis undergoing treatment with palliative radiotherapy and tapentadol: A prospective multicentre pilot study

To assess pain response rate (RR) and quality of life (QoL), in patients with moderate/severe neuropathic pain (NP) due to bone metastasis (BM) undergoing palliative 3D radiotherapy plus tapentadol.

[1]  M. Lock,et al.  Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  N. Oya,et al.  Pain Response Rates After Conventional Radiation Therapy for Bone Metastases in Prospective Nonrandomized Studies: A Systematic Review. , 2019, Practical radiation oncology.

[3]  T. Naiki,et al.  Efficacy of tapentadol for first-line opioid-resistant neuropathic pain in Japan , 2018, Japanese journal of clinical oncology.

[4]  K. Ding,et al.  Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23 , 2017, JAMA oncology.

[5]  P. Hoskin,et al.  How should radiation oncologists interpret the ASTRO evidence-based guideline and ASTRO Choosing Wisely campaign for the treatment of uncomplicated bone metastases? , 2017, Practical radiation oncology.

[6]  Liying Zhang,et al.  The incidence of neuropathic pain in bone metastases patients referred for palliative radiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  C. Marijnen,et al.  Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases. , 2015, International journal of radiation oncology, biology, physics.

[8]  P. Wiffen,et al.  Oral tapentadol for cancer pain. , 2015, The Cochrane database of systematic reviews.

[9]  João Costa,et al.  Tapentadol for chronic musculoskeletal pain in adults. , 2015, The Cochrane database of systematic reviews.

[10]  C. Marijnen,et al.  Effect of age on response to palliative radiotherapy and quality of life in patients with painful bone metastases. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Liying Zhang,et al.  Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22. , 2012, International journal of radiation oncology, biology, physics.

[12]  Y. M. van der Linden,et al.  Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. , 2012, International journal of radiation oncology, biology, physics.

[13]  V. López-Gómez,et al.  Prevalence of neuropathic pain in radiotherapy oncology units. , 2011, International journal of radiation oncology, biology, physics.

[14]  M. Bennett,et al.  Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Reid,et al.  The management of cancer‐related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland , 2009, European journal of pain.

[16]  J. C. Galcerán,et al.  Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  M. Bennett,et al.  Using screening tools to identify neuropathic pain , 2007, PAIN.

[18]  John H Suh,et al.  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. , 2005, Journal of the National Cancer Institute.

[19]  P. Hoskin,et al.  Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  M. Mason,et al.  Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials. , 2003, The Cochrane database of systematic reviews.

[21]  M. Johnston,et al.  Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. , 2003, International journal of radiation oncology, biology, physics.

[22]  Cancer Care Ontario Practice Guidelines Initiative , 2003 .